Form 8-K · Current Report · Filed 2025-09-18
McKesson Reorganizes into Four Reportable Segments
McKesson Corporation announced a reorganization into four reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions, effective from the second quarter of fiscal 2026.
- Filer
- McKesson Corporation MCK · NYSE
- Filed
- Accession
- 0000927653-25-000121
- CIK
- 0000927653
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
This realignment reflects how the Chief Executive Officer allocates resources and assesses performance. The segment changes do not impact previously issued consolidated financial statements or historical earnings per share. Supplemental historical financial information by the new reportable segments is provided in Exhibit 99.1.
Items reported
Financial Statements and Exhibits
Market reaction
Close before filing
$692.24
Next session
+0.9%
Since filing
+23.7%
Latest close
$856.19
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MCK reporting the same item, with the next session's move:
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Never miss another MCK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.